Aptose Biosciences
APTO
#10466
Rank
NZ$7.56 M
Marketcap
NZ$2.96
Share price
0.00%
Change (1 day)
768.49%
Change (1 year)

Aptose Biosciences (APTO) - Total assets

Total assets on the balance sheet as of March 2025 : NZ$12.94 Million

According to Aptose Biosciences's latest financial reports the company's total assets are NZ$12.94 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Aptose Biosciences - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2023-12-31NZ$20.53 M-74.44%
2022-12-31NZ$80.37 M-33.48%
2021-12-31NZ$0.12 B-30.96%
2020-12-31NZ$0.17 B17.29%
2019-12-31NZ$0.14 B493.2%
2018-12-31NZ$25.15 M49.26%
2017-12-31NZ$16.85 M35%
2016-12-31NZ$12.48 M-44.36%
2015-12-31NZ$22.43 M
2014-05-31NZ$33.52 M2598.46%
2013-05-31NZ$1.24 M44.44%
2012-05-31NZ$0.86 M-50.38%
2011-05-31NZ$1.73 M-46.21%
2010-05-31NZ$3.22 M-69.72%
2009-05-31NZ$10.64 M-28.55%
2008-05-31NZ$14.89 M-21.53%
2007-05-31NZ$18.98 M14.57%
2006-05-31NZ$16.56 M-47.06%
2005-05-31NZ$31.29 M-22.04%
2004-05-31NZ$40.14 M-7.14%
2003-05-31NZ$43.22 M-34.05%
2002-05-31NZ$65.55 M-32.02%
2001-05-31NZ$96.43 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Advaxis
ADXS
NZ$28.74 M 122.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
NZ$0.21 B 1,575.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
NZ$1.42 B 10,909.79%๐Ÿ‡บ๐Ÿ‡ธ USA